US equities |
MU $1,041.85 ▼-4.24% NVDA $232.02 ▼-2.30% SNDK $1,591.65 ▼-5.95% AMD $620.00 ▼-4.00% INTC $106.66 ▼-5.71% SPCX $161.06 ▼-3.90% PLTR $197.63 ▲+1.81% META $715.18 ▼-0.85%
FinancialContent

Latest News about Psychedelics R&D

Recent news which mentions Psychedelics R&D

MindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path Upheld
Tickers MNMD
Tags Management Benzinga MNMD
From Benzinga
Mydecine Innovations Group Reports Q2 Financial Results And Management Updates
Tickers MYCOF
Tags Earnings Markets Psychedelics
From Benzinga
Report: Psychedelic Therapeutics Global Market Could Be Worth $8.31B By 2028
Tags Global InsightAce Analytic Psychedelics Mergers And Acquisitions
From Benzinga
Gilgamesh Advances Pipeline Of Novel Psychoactive Drugs Aimed At Revolutionizing Psychiatric Disorders Treatment
Tags Benzinga Classic Psychedelics Analogs Management
From Benzinga